تداخل‌های دارویی
Glimepiride-pioglitazone + Insulin aspart
شدت: شدید
Glimepiride-pioglitazone and Insulin aspart: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Combining insulin with glimepiride and pioglitazone increases the risk of hypoglycemia. Insulin with pioglitazone also raises the risk of fluid retention, edema and heart failure.
معنای این تداخل به زبان ساده
Glimepiride-pioglitazone and Insulin aspart can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Glimepiride-pioglitazone belongs to Endocrine; Insulin aspart belongs to Endocrine.
چرا رخ می‌دهد
Additive glucose lowering, and thiazolidinedione-induced sodium and fluid retention is amplified by insulin.
اقدام لازم
Reduce insulin or sulfonylurea doses as needed and monitor glucose. Watch for weight gain, edema and heart failure symptoms, particularly in patients with cardiac risk.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Glimepiride-pioglitazone و Insulin aspart، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Glimepiride-pioglitazone
تداخلات دیگر Insulin aspart
پرسش‌های متداول
Can I take Glimepiride-pioglitazone with Insulin aspart?
MediHelp rates the interaction as major. Glimepiride-pioglitazone and Insulin aspart can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Combining insulin with glimepiride and pioglitazone increases the risk of hypoglycemia. Insulin with pioglitazone also raises the risk of fluid retention, edema and heart failure.
How serious is the interaction between Glimepiride-pioglitazone and Insulin aspart?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce insulin or sulfonylurea doses as needed and monitor glucose. Watch for weight gain, edema and heart failure symptoms, particularly in patients with cardiac risk.
What other medicines interact with Glimepiride-pioglitazone?
MediHelp also lists interactions of Glimepiride-pioglitazone with, for example, Fluconazole, Gemfibrozil, Insulin degludec. The full list is on the Glimepiride-pioglitazone page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
